Abstract
Effects of Long-Term Ruxolitinib (RUX) on Bone Marrow (BM) Morphology in Patients with Myelofibrosis (MF) Enrolled in the COMFORT-I Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have